Clinical benefits for CRT-D over ICD even with comorbidity

May 10, 2017

(HealthDay)—For patients with left bundle branch block, the benefit of cardiac resynchronization therapy with defibrillator (CRT-D) over implantable cardioverter-defibrillator (ICD) alone persists with comorbidity, according to a study published in the May 16 issue of the Journal of the American College of Cardiology.

Emily P. Zeitler, M.D., from Duke University Hospital in Durham, N.C., and colleagues examined the correlation of multiple comorbidities with the benefits of CRT-D over ICD alone in 1,214 patients with left bundle branch block and zero, one, two, or three or more comorbidities.

The researchers identified an inverse correlation between comorbidity burden and improvements in left ventricular (LV) end-systolic volume, LV end-diastolic volume, LV ejection fraction, left atrial volume, and LV dyssynchrony. Regardless of treatment group, there was an increasing risk of death or nonfatal heart failure events with increasing comorbidity burden in an adjusted model (P < 0.001). There was no interaction with respect to comorbidity burden and the benefit of CRT-D versus ICD only for death or nonfatal heart failure events during a mean follow-up of 4.65 years (interaction, P = 0.943). The absolute risk reduction associated with CRT-D versus ICD alone was greater for groups with the greatest comorbidity burden versus those with less comorbidity burden (2 and ≥3 versus 0 and 1).

"The burden of comorbidity does not appear to compromise the clinical benefits of CRT-D compared with ICD alone," the authors write.

Several authors disclosed financial ties to the pharmaceutical and medical device industries.

Explore further: Adding defibrillator to CRT no benefit in dilated cardiomyopathy

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Adding defibrillator to CRT no benefit in dilated cardiomyopathy

April 3, 2017
(HealthDay)—For patients with heart failure with indications for cardiac resynchronization therapy (CRT), those with ischemic cardiomyopathy (ICM), but not those with nonischemic dilated cardiomyopathy (DCM), benefit from ...

Prostate cancer interacts with comorbidity to increase VTE rate

July 21, 2015
(HealthDay)—For men with prostate cancer (PC), the rate of venous thromboembolism (VTE) is increased with high comorbidity, according to a study published online July 6 in Cancer.

Longer LOS for new heart failure in medicaid patients

March 4, 2014
(HealthDay)—Medicaid patients and patients with more comorbidities have a longer length of stay (LOS) for incident heart failure, compared to other hospitalized cases, according to a study published in the January/February ...

Chronic kidney disease patients benefit from pacing left and right ventricles

December 7, 2015
Patients with moderate-to-severe chronic kidney disease who received cardiac resynchronization therapy with defibrillator had a lower risk of hospitalization for heart failure or death from this condition compared to patients ...

PR interval prognostic of cardiac resynchronization Tx outcome

February 15, 2017
(HealthDay)—For patients with advanced systolic heart failure, the impact of cardiac resynchronization therapy with defibrillation (CRT-D) varies according to PR interval, according to research published in the February ...

Comorbid conditions associated with worse lung cancer survival

June 11, 2015
Main Findings: Lung cancer patients with comorbid conditions such as chronic obstructive pulmonary disease, diabetes, or congestive heart failure had a higher risk of death than lung cancer patients without comorbid conditions.

Recommended for you

Can stem cells help a diseased heart heal itself? Researchers achieve important milestone

December 14, 2018
A team of Rutgers scientists, including Leonard Lee and Shaohua Li, have taken an important step toward the goal of making diseased hearts heal themselves—a new model that would reduce the need for bypass surgery, heart ...

Your weight history may predict your heart failure risk

December 12, 2018
In a medical records analysis of information gathered on more than 6,000 people, Johns Hopkins Medicine researchers conclude that simply asking older adult patients about their weight history at ages 20 and 40 could provide ...

New understanding of mysterious 'hereditary swelling'

December 12, 2018
For the first time ever, biomedical researchers from Aarhus University, Denmark, report cellular defects that lead to a rare disease, hereditary angioedema (HAE), in which patients experience recurrent episodes of swelling ...

Higher risk of heart attack on Christmas Eve

December 12, 2018
The risk of heart attack peaks at around 10pm on Christmas Eve, particularly for older and sicker people, most likely due to heightened emotional stress, finds a Swedish study in this week's Christmas issue of The BMJ.

Age is the biggest risk for heart disease, but lifestyle and meds have impact

December 12, 2018
Of all the risk factors for heart disease, age is the strongest predictor of potential trouble.

Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes

December 11, 2018
Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.